首页> 外文期刊>中国神经再生研究(英文版) >Botulinum toxin type A plus rehabilitative training for improving the motor function of the upper limbs and activities of daily life in patients with stroke and brain injury
【24h】

Botulinum toxin type A plus rehabilitative training for improving the motor function of the upper limbs and activities of daily life in patients with stroke and brain injury

机译:A型肉毒杆菌毒素和康复训练,可改善中风和脑损伤患者的上肢运动功能和日常生活活动

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Botulinum toxin type A (BTX-A) is mostly to be used to treat various diseases of motor disorders, whereas its effect on muscle spasm after stroke and brain injury needs further observation.OBJECTIVE : To observe the effect of BTX-A plus rehabilitative training on treating muscle spasm after stroke and brain injury.DESIGN: A randomized controlled observation.SETTINGS: Department of Rehabilitation, Department of Neurology and Department of Neurosurgery, the Second Hospital of Hebei Medical University.PARTICIPANTS: Sixty inpatients with brain injury and stroke were selected from the Department of Rehabilitation, Department of Neurology and Department of Neurosurgery, the Second Hospital of Hebei Medical University from January 2001 to August 2006. They were all confirmed by CT and MRI, and had obvious increase of spastic muscle strength in upper limbs, their Ashworth grades were grade 2 or above. The patients were randomly divided into treatment group (n =30) and control group (n =30).METHODS: ① Patients in the treatment group undertook comprehensive rehabilitative trainings, and they were administrated with domestic BTX-A, which was provided by Lanzhou Institute of Biological Products, Ministry of Health (S10970037), and the muscles of flexion spasm were selected for upper limbs, 20-25 IU for each site.② Patients in the treatment group were assessed before injection and at 1 and 2 weeks, 1 and 3 months after injection respectively, and those in the control group were assessed at corresponding time points. The recovery of muscle spasm was assessed by modified Ashworth scale (MAS, grade 0-Ⅳ; Grade 0 for without increase of muscle strength; Grade Ⅳ for rigidity at passive flexion and extension); The recovery of motor function of the upper limbs was evaluated with Fugl-Meyer Assessment (FMA, total score was 226 points, including 100 for exercise, 14 for balance, 24 for sense, 44 for joint motion, 44 for pain and 66 for upper limb); The ADL were evaluated with Barthel index, the total score was 100 points, 60 for mild dysfunction, 60-41 for moderate dysfunction, < 40 for severe dysfunction).MAIN OUTCOME MEASURES: Changes of MAS grade, FMA scores and Barthel index before and after BTX-A injection.RESULTS: All the 60 patients with brain injury and stroke were involved in the analysis of results. ① FMA scores of upper limbs: The FMA score in the treatment group at 2 weeks after treatment was higher than that before treatment [(14.98±10.14), (13.10±9.28) points, P< 0.05], whereas there was no significant difference at corresponding time point in the control group. The FMA scores at 1 and 3 months in the treatment group [(23.36±10.69), (35.36±11.36) points] were higher than those in the control group [(20.55±10.22), (30.33±10.96) points, P < 0.01]. ② MAS grades of upper limbs: There were obviously fewer cases of grade Ⅲ in MAS at 2 weeks after treatment than before treatment in the treatment group (0, 9 cases, P <0.05), whereas there was no obvious difference in the control group. There were obviously fewer cases of grade Ⅲ in MAS at 2 weeks and 1 month after treatment in the treatment group (0, 0 case) than the control group (5, 2 cases, P < 0.01). ③ Barthel index of upper limbs: The Barthel index at 2 weeks after treatment was higher than that before treatment in the treatment group [(30.36±22.25), (28.22±26.21) points, P< 0.05],whereas there was no significant difference in the control group. The Barthel indexes at 1 and 3 months after treatment in the treatment group were obviously higher than those in the control group [(20.55±10.22), (30.33±10.96) points, P< 0.01].CONCLUSION: BTX-A has obvious efficacy on decreasing muscle tension after stroke and brain injury, and relieving muscle spasm; Meanwhile, the combination with rehabilitative training can effectively ameliorate the motor function of upper limbs and ADL of the patients.
机译:背景:A型肉毒杆菌毒素(BTX-A)主要用于治疗各种运动障碍疾病,但其对中风和脑损伤后肌肉痉挛的作用尚待进一步观察。目的:观察BTX-A plus的作用脑卒中和脑损伤后肌肉痉挛的康复训练设计:随机对照观察背景:河北医科大学第二医院神经内科和神经外科科康复科对象:60名脑损伤和中风住院患者从2001年1月至2006年8月从河北医科大学第二医院康复科,神经内科和神经外科科选取。均经CT和MRI证实,上肢痉挛性肌力明显增加,其Ashworth成绩为2级或更高。方法将患者随机分为治疗组(n = 30)和对照组(n = 30)。①治疗组患者接受了全面的康复训练,并接受了兰州提供的国产BTX-A的管理。卫生部生物制品研究所(S10970037),选择上肢屈曲痉挛的肌肉,每个部位20-25IU。②治疗组在注射前,第1和第2周进行评估,1分别在注射后3个月和3个月,以及对照组在相应的时间点进行评估。肌肉痉挛的恢复情况通过改良的Ashworth量表(MAS,0-Ⅳ级; 0表示不增加肌肉力量;Ⅳ级:在被动屈伸时的僵硬程度)进行评估;通过Fugl-Meyer评估(FMA,总分226分,包括运动100分,平衡14分,感觉24分,关节运动44分,疼痛44分和上肢66分)评估上肢运动功能的恢复肢);采用Barthel指数对ADL进行评估,总分100分,轻度功能障碍60分,中度功能障碍60-41分,重度功能障碍60分至41分。主要观察指标:术前和术后MAS评分,FMA评分和Barthel指数的变化结果:60例脑外伤和中风患者全部进入结果分析。 ①上肢FMA评分:治疗组治疗2周后的FMA评分高于治疗前[(14.98±10.14),(13.10±9.28)分,P <0.05],差异无统计学意义。在对照组的相应时间点。治疗组在1个月和3个月时的FMA评分[(23.36±10.69),(35.36±11.36)分]高于对照组[(20.55±10.22),(30.33±10.96)分,P < 0.01]。 ②上肢MAS分级:治疗后2周,MASⅢ级病例明显少于治疗前(0、9例,P <0.05),而对照组无明显差异。 。治疗组(0,0例)在治疗后2周和1个月时MASⅢ级病例明显少于对照组(5,2例,P <0.01)。 ③上肢Barthel指数:治疗后2周Barthel指数高于治疗组[(30.36±22.25),(28.22±26.21)分,P <0.05],差异无统计学意义。在对照组中。治疗组治疗后1、3个月的Barthel指数明显高于对照组[(20.55±10.22),(30.33±10.96)分,P <0.01]。结论:BTX-A有明显疗效减轻中风和脑损伤后的肌肉紧张,缓解肌肉痉挛;同时,结合康复训练可以有效改善患者上肢的运动功能和ADL。

著录项

  • 来源
    《中国神经再生研究(英文版)》 |2006年第9期|859-861|共3页
  • 作者单位

    Department of Rehabilitation,Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China;

    Department of Rehabilitation,Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China;

    Department of Rehabilitation,Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China;

    Department of Rehabilitation,Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China;

    Department of Rehabilitation,Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 神经病学与精神病学;
  • 关键词

  • 入库时间 2022-08-19 03:44:52
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号